174 related articles for article (PubMed ID: 37161425)
21.
Liu Z; Ren Z; Zhang C; Qian R; Wang H; Wang J; Zhang W; Liu B; Lian X; Wang Y; Guo Y; Gao Y
Front Oncol; 2021; 11():608748. PubMed ID: 34976781
[TBL] [Abstract][Full Text] [Related]
22. KDELR2 is an unfavorable prognostic biomarker and regulates CCND1 to promote tumor progression in glioma.
Mao H; Nian J; Wang Z; Li X; Huang C
Pathol Res Pract; 2020 Jul; 216(7):152996. PubMed ID: 32534703
[TBL] [Abstract][Full Text] [Related]
23. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
24. Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38/snail1 pathway in glioma.
Liu J; Gao L; Liao J; Yang J; Yuan F; Chen Q
Ann Transl Med; 2021 Feb; 9(3):260. PubMed ID: 33708887
[TBL] [Abstract][Full Text] [Related]
25. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-202 inhibits cell proliferation, migration and invasion of glioma by directly targeting metadherin.
Yang J; Fan B; Zhao Y; Fang J
Oncol Rep; 2017 Sep; 38(3):1670-1678. PubMed ID: 28714009
[TBL] [Abstract][Full Text] [Related]
27. RGS16 promotes glioma progression and serves as a prognostic factor.
Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
[TBL] [Abstract][Full Text] [Related]
28. CUX1 Facilitates the Development of Oncogenic Properties
Feng F; Zhao Z; Zhou Y; Cheng Y; Wu X; Heng X
Front Mol Biosci; 2021; 8():705008. PubMed ID: 34422906
[No Abstract] [Full Text] [Related]
29. circCPA4 acts as a prognostic factor and regulates the proliferation and metastasis of glioma.
Peng H; Qin C; Zhang C; Su J; Xiao Q; Xiao Y; Xiao K; Liu Q
J Cell Mol Med; 2019 Oct; 23(10):6658-6665. PubMed ID: 31424161
[TBL] [Abstract][Full Text] [Related]
30. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
31. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
[TBL] [Abstract][Full Text] [Related]
32. APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma.
Zhu H; Hu X; Feng S; Li Y; Zhang Y; Qiu S; Chen R; Ye Y; Gu L; Jian Z; Xu X; Xiong X
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233633
[TBL] [Abstract][Full Text] [Related]
33. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
34. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
35. CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells.
Wu H; Zhou Y; Wu H; Xu L; Yan Y; Tong X; Yan H
Front Genet; 2021; 12():732376. PubMed ID: 34646306
[No Abstract] [Full Text] [Related]
36. Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma.
Li Y; Zhang Y; Wu Z; Sun P
BMC Neurol; 2023 Jan; 23(1):17. PubMed ID: 36639743
[TBL] [Abstract][Full Text] [Related]
37. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
Mu M; Niu W; Zhang X; Hu S; Niu C
Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
[TBL] [Abstract][Full Text] [Related]
38. TRAF3IP3 promotes glioma progression through the ERK signaling pathway.
Lin Q; Chen Z; Shen ZL; Xue F; Qin JJ; Kang XP; Chen ZR; Xia ZY; Gao L; Chen XZ
Front Oncol; 2022; 12():776834. PubMed ID: 36185204
[TBL] [Abstract][Full Text] [Related]
39. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
40. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
